CMC

SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against PolarityTE, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Monday, September 27, 2021 - 8:57pm

Investors who purchased the Company's securities between April 30, 2020 and August 23, 2021, inclusive (the ''Class Period''), are encouraged to contact the firm before November 23, 2021.

Key Points: 
  • Investors who purchased the Company's securities between April 30, 2020 and August 23, 2021, inclusive (the ''Class Period''), are encouraged to contact the firm before November 23, 2021.
  • We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
  • The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

Associa Community Management Corporation Hires Hilary Bradley as Business Development Director

Monday, September 27, 2021 - 7:45pm

Chantilly, VA, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Associa Community Management Corporation (CMC) announces Hilary Bradley as the new business development director.

Key Points: 
  • Chantilly, VA, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Associa Community Management Corporation (CMC) announces Hilary Bradley as the new business development director.
  • Ms. Bradley joins Associa with more than 25 years of sales, marketing, account management, and strategic planning experience.
  • Ms. Bradley is a graduate of the University of Maryland, where she earned her Bachelor of Science in retail marketing.
  • With more than 200 branch offices across North America, Associa delivers unsurpassed management and lifestyle services to nearly five million residents worldwide.

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages PolarityTE, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – PTE

Monday, September 27, 2021 - 5:57pm

WHAT TO DO NEXT: To join the PolarityTE class action, go to http://www.rosenlegal.com/cases-register-2163.html or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the PolarityTE class action, go to http://www.rosenlegal.com/cases-register-2163.html or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Zeus Electric Chassis, Inc. to be Featured in Mobility Product Showcase at E Source Forum 2021

Monday, September 27, 2021 - 5:45pm

Zeus Electric Chassis, Inc. (Zeus) is one of six innovators in the mobility industry invited to participate in a Mobility Product Showcase.

Key Points: 
  • Zeus Electric Chassis, Inc. (Zeus) is one of six innovators in the mobility industry invited to participate in a Mobility Product Showcase.
  • Bill Brandt, Zeus Chief Revenue Officer, will present a short video about Zeus Electric Chassis and participate in an open Q&A session.
  • In the case of Zeus, E Source will join the CMC and the Sacramento Municipal Utility District (SMUD) to independently evaluate Zeus product performance.
  • Learn more about E Source at www.esource.com, and learn more about the forum at www.web.cvent.com/event/5accf916-e3e5-4742-9a54-91628c39fdfe/summary .

AnHeart and Innovent Announce Interim Data from Phase Ⅱ Trial (TRUST) of Taletrectinib in ROS1-Positive NSCLC at the CSCO 2021 Annual Meeting

Monday, September 27, 2021 - 1:00pm

The data was announced as a keynote presentation at the Chinese Society of Clinical Oncology (CSCO) 2021 Annual Meeting on September 25-29, 2021.

Key Points: 
  • The data was announced as a keynote presentation at the Chinese Society of Clinical Oncology (CSCO) 2021 Annual Meeting on September 25-29, 2021.
  • The scientific presentation entitled: Taletrectinib (AB-106): Preliminary results from TRUST, Phase trial of a new generation of potent ROS1/NTRK inhibitors in ROS1-positive non-small cell lung cancer (NSCLC), summarized preliminary data from an ongoing Phase trial of taletrectinib (NCT04395677).
  • Our team is focused on completing patient enrollment for our Phase TRUST trial, said Bing Yan, MD, Co-founder and Chief Medical Officer at AnHeart Therapeutics.
  • The interim data presented builds a strong foundation for our ongoing global pivotal taletrectinib clinical program.

Eco Depot Inc announces excellent ASTM Water Vapor transmission test results

Monday, September 27, 2021 - 12:45pm

ASTM E-96 was used to determine the water vapor transmission for outdoor use.

Key Points: 
  • ASTM E-96 was used to determine the water vapor transmission for outdoor use.
  • The painted surface of the sample faced the water in the tray, while the unfinished portion was exposed to ambient air.
  • These ASTM E-96 tests further prove efficacy in water vapor transmission of the product's application on foundations and envelopes (Facades).
  • These ASTM E-96 water vapor transmissions tests results prove the effectiveness and added value to our Faade and Aquablock product line to protecting your building envelope against water damage to the concrete facade and foundations.

NanoViricides, Inc. Invites You to Join Us at the Benzinga Healthcare Small Cap Conference for Update on Pan-Coronavirus COVID-19 Drug Development Program

Monday, September 27, 2021 - 11:45am

The Benzinga Healthcare Small Cap Conference bridges the gap between Small Cap companies, investors, and traders.

Key Points: 
  • The Benzinga Healthcare Small Cap Conference bridges the gap between Small Cap companies, investors, and traders.
  • Learn about small cap investing with clearly defined Educational Modules, take a look at a curated group of Small Cap investment opportunities, and connect with the healthcare Small Cap audience in an intimate, virtual setting.
  • We invite investors and all interested parties to explore healthcare small cap investment opportunities through two days of networking, dealmaking and discovery.
  • The NV-HHV-101 program was slowed down because of the effects of recent COVID-19 restrictions, and re-prioritization for COVID-19 drug development work.

GenScript ProBio and AskGene Enter into a Non-exclusive License of A sdAb Targeting Immune Checkpoint Target

Sunday, September 26, 2021 - 3:28pm

NANJING, China, Sept. 26, 2021 /PRNewswire/ -- On September 26, 2021, GenScript ProBio and AskGene signed a license agreement for GenScript ProBio's single-domain antibody (sdAb) targeting an immune checkpoint target.

Key Points: 
  • NANJING, China, Sept. 26, 2021 /PRNewswire/ -- On September 26, 2021, GenScript ProBio and AskGene signed a license agreement for GenScript ProBio's single-domain antibody (sdAb) targeting an immune checkpoint target.
  • GenScript ProBio grants a non-exclusive global license to AskGene to use GenScript ProBio's sdAb targeting immune checkpoint target for discovery, development and commercialization of its antibody and derivative products.
  • Since the establishment of its sdAb discovery platform in 2010, GenScript has accumulated over 11 years of sdAb research and development experience.
  • At present, GenScript ProBio has built up integrated sdAb immune library, sdAb nave library, sdAb humanization, antibody screening and functional validation platforms.

­CMC-Rose Institute poll gauges voter attitudes on two coasts

Friday, September 24, 2021 - 10:00am

The poll, designed by the Rose Institute and conducted by YouGov, surveyed 2,000 respondents in California and 1,675 in New York between August 30, 2021 and September 10, 2021.

Key Points: 
  • The poll, designed by the Rose Institute and conducted by YouGov, surveyed 2,000 respondents in California and 1,675 in New York between August 30, 2021 and September 10, 2021.
  • Andrew Sinclair and Ken Miller oversaw and developed the poll comparing political attitudes in California and New York states.
  • The CMC-Rose Institute Poll was sponsored and funded by the Rose Institute of State and Local Government and Claremont McKenna College.
  • The margin of error in the New York registered voter sample is 2.83, a slightly larger weight reflecting a slightly smaller group.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sesen Bio, Inc. of Class Action Lawsuit and Upcoming Deadline – SESN

Friday, September 24, 2021 - 12:38am

To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.

Key Points: 
  • To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Sesen Bio is a late-stage clinical company that purports to advance targeted fusion protein (TFP) therapeutics for cancer treatments.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.